VIRAL VECTOR CORE

$95,367P30FY2008DKNIH

University Of Pennsylvania, Philadelphia PA

Investigators

Linked publications & trials

Paper 39665757 Paper 39509517 Paper 39485282 Paper 39413791 Paper 39345402 Paper 39266447 Paper 39184090 Paper 39109797 Paper 39083653 Paper 39048792 Paper 38984949 Paper 38950317 Paper 38918428 Paper 38889724 Paper 38879678 Paper 38821056 Paper 38775132 Paper 38702321 Paper 38701745 Paper 38677282 Paper 38668312 Paper 38657025 Paper 38622413 Paper 38496495 Paper 38471656 Paper 38464137 Paper 38444582 Paper 38364948 Paper 38290087 Paper 38287030 Paper 38266068 Paper 38218536 Paper 38200130 Paper 38142970 Paper 37910501 Paper 37906287 Paper 37874683 Paper 37872177 Paper 37850099 Paper 37848036 Paper 37808824 Paper 37802574 Paper 37802078 Paper 37802023 Paper 37756255 Paper 37738117 Paper 37725835 Paper 37693606 Paper 37647897 Paper 37611750 Paper 37503734 Paper 37463421 Paper 37300599 Paper 37283808 Paper 37236193 Paper 37235682 Paper 37224913 Paper 37134024 Paper 37100997 Paper 37068109 Paper 37066875 Paper 37037491 Paper 37023747 Paper 36993336 Paper 36927960 Paper 36914909 Paper 36857182 Paper 36799021 Paper 36778447 Paper 36768194 Paper 36763336 Paper 36753562 Paper 36745673 Paper 36732547 Paper 36712052 Paper 36711451 Paper 36517598 Paper 36503150 Paper 36476934 Paper 36223763 Paper 36219563 Paper 36208986 Paper 36107856 Paper 36086823 Paper 36073526 Paper 36070684 Paper 36070683 Paper 36026493 Paper 35939699 Paper 35848549 Paper 35796669 Paper 35758724 Paper 35717342 Paper 35708349 Paper 35705000 Paper 35663017 Paper 35642629 Paper 35576592 Paper 35477756 Paper 35450819

Abstract

VIRAL VECTOR CORE: Director-J. Johnston The main objective of the Vector Core is to provide DERC center members access to state-of-theart vector technology for preclinical studies. In order to facilitate vector creation and production, the professional staff, using a state-of-the-art facility, will carry out the following: 1) Production of viral vectors derived from adeno-associated viruses (AAV), adenoviruses, and lentiviruses as well as the production of non-viral vectors for use in basic research; 2) Work with DERC Investigators to develop vectors or recombinant viruses specifically of use to DERC members; 3) Development of gene transfer vectors that will be superior to those of previous generations; 4) Submission of the vectors produced to the Bioassay Core to determine the quantity, purity and potency of the vectors produced; 5) Development of a web-based database to enable DERC members to request services, monitor the status of vector production, and access historical data on vectors produced by their laboratory.

View original record on NIH RePORTER →